2-[(11R)-8-[3-(4,5-dihydro-1H-imidazol-2-ylamino)propyl]-3,6,9,12,15-pentaoxo-11-propan-2-yl-14-[[4-[3-[[6-[2-[(2-sulfophenyl)methylidene]hydrazinyl]pyridine-3-carbonyl]amino]propoxy]phenyl]methyl]-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid

C44H56N12O12S — CID 58635064

IUPAC2-[(11R)-8-[3-(4,5-dihydro-1H-imidazol-2-ylamino)propyl]-3,6,9,12,15-pentaoxo-11-propan-2-yl-14-[[4-[3-[[6-[2-[(2-sulfophenyl)methylidene]hydrazinyl]pyridine-3-carbonyl]amino]propoxy]phenyl]methyl]-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid
SMILESCC(C)[C@H]1NC(=O)C(CCCNC2=NCCN2)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(OCCCNC(=O)c3ccc(NN=Cc4ccccc4S(=O)(=O)O)nc3)cc2)NC1=O
InChIInChI=1S/C44H56N12O12S/c1-26(2)38-43(64)54-32(42(63)53-33(22-37(58)59)40(61)50-25-36(57)52-31(41(62)55-38)8-5-16-46-44-47-18-19-48-44)21-27-10-13-30(14-11-27)68-20-6-17-45-39(60)29-12-15-35(49-23-29)56-51-24-28-7-3-4-9-34(28)69(65,66)67/h3-4,7,9-15,23-24,26,31-33,38H,5-6,8,16-22,25H2,1-2H3,(H,45,60)(H,49,56)(H,50,61)(H,52,57)(H,53,63)(H,54,64)(H,55,62)(H,58,59)(H2,46,47,48)(H,65,66,67)/t31?,32?,33?,38-/m1/s1
InChIKeyUQGHRBPUYPCKDD-WIXSAIQQSA-N
MW977.07 g/mol
LogP-0.96
Rot. Bonds19

About 2-[(11R)-8-[3-(4,5-dihydro-1H-imidazol-2-ylamino)propyl]-3,6,9,12,15-pentaoxo-11-propan-2-yl-14-[[4-[3-[[6-[2-[(2-sulfophenyl)methylidene]hydrazinyl]pyridine-3-carbonyl]amino]propoxy]phenyl]methyl]-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid

2-[(11R)-8-[3-(4,5-dihydro-1H-imidazol-2-ylamino)propyl]-3,6,9,12,15-pentaoxo-11-propan-2-yl-14-[[4-[3-[[6-[2-[(2-sulfophenyl)methylidene]hydrazinyl]pyridine-3-carbonyl]amino]propoxy]phenyl]methyl]-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid (PubChem CID 58635064) has the molecular formula C44H56N12O12S and a molecular weight of 977.07 g/mol. Its IUPAC name is 2-[(11R)-8-[3-(4,5-dihydro-1H-imidazol-2-ylamino)propyl]-3,6,9,12,15-pentaoxo-11-propan-2-yl-14-[[4-[3-[[6-[2-[(2-sulfophenyl)methylidene]hydrazinyl]pyridine-3-carbonyl]amino]propoxy]phenyl]methyl]-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid.

Molecular Properties

Compound Name2-[(11R)-8-[3-(4,5-dihydro-1H-imidazol-2-ylamino)propyl]-3,6,9,12,15-pentaoxo-11-propan-2-yl-14-[[4-[3-[[6-[2-[(2-sulfophenyl)methylidene]hydrazinyl]pyridine-3-carbonyl]amino]propoxy]phenyl]methyl]-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid
PubChem CID58635064
Molecular FormulaC44H56N12O12S
Molecular Weight977.07 g/mol
Exact Mass976.39
IUPAC Name2-[(11R)-8-[3-(4,5-dihydro-1H-imidazol-2-ylamino)propyl]-3,6,9,12,15-pentaoxo-11-propan-2-yl-14-[[4-[3-[[6-[2-[(2-sulfophenyl)methylidene]hydrazinyl]pyridine-3-carbonyl]amino]propoxy]phenyl]methyl]-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid
SMILESCC(C)[C@H]1NC(=O)C(CCCNC2=NCCN2)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(OCCCNC(=O)c3ccc(NN=Cc4ccccc4S(=O)(=O)O)nc3)cc2)NC1=O
InChIInChI=1S/C44H56N12O12S/c1-26(2)38-43(64)54-32(42(63)53-33(22-37(58)59)40(61)50-25-36(57)52-31(41(62)55-38)8-5-16-46-44-47-18-19-48-44)21-27-10-13-30(14-11-27)68-20-6-17-45-39(60)29-12-15-35(49-23-29)56-51-24-28-7-3-4-9-34(28)69(65,66)67/h3-4,7,9-15,23-24,26,31-33,38H,5-6,8,16-22,25H2,1-2H3,(H,45,60)(H,49,56)(H,50,61)(H,52,57)(H,53,63)(H,54,64)(H,55,62)(H,58,59)(H2,46,47,48)(H,65,66,67)/t31?,32?,33?,38-/m1/s1
InChIKeyUQGHRBPUYPCKDD-WIXSAIQQSA-N
XLogP-0.96
TPSA349.20 Ų
H-Bond Donors11
H-Bond Acceptors16
Rotatable Bonds19
Heavy Atoms69
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500977.07
LogP ≤ 5-0.96
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'Sulfonic_acid_2', 'substructure': 'N/A'}

Analyze 2-[(11R)-8-[3-(4,5-dihydro-1H-imidazol-2-ylamino)propyl]-3,6,9,12,15-pentaoxo-11-propan-2-yl-14-[[4-[3-[[6-[2-[(2-sulfophenyl)methylidene]hydrazinyl]pyridine-3-carbonyl]amino]propoxy]phenyl]methyl]-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(11R)-8-[3-(4,5-dihydro-1H-imidazol-2-ylamino)propyl]-3,6,9,12,15-pentaoxo-11-propan-2-yl-14-[[4-[3-[[6-[2-[(2-sulfophenyl)methylidene]hydrazinyl]pyridine-3-carbonyl]amino]propoxy]phenyl]methyl]-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid?
The IUPAC name of 2-[(11R)-8-[3-(4,5-dihydro-1H-imidazol-2-ylamino)propyl]-3,6,9,12,15-pentaoxo-11-propan-2-yl-14-[[4-[3-[[6-[2-[(2-sulfophenyl)methylidene]hydrazinyl]pyridine-3-carbonyl]amino]propoxy]phenyl]methyl]-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid (CID 58635064) is 2-[(11R)-8-[3-(4,5-dihydro-1H-imidazol-2-ylamino)propyl]-3,6,9,12,15-pentaoxo-11-propan-2-yl-14-[[4-[3-[[6-[2-[(2-sulfophenyl)methylidene]hydrazinyl]pyridine-3-carbonyl]amino]propoxy]phenyl]methyl]-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid.
What is the SMILES notation for 2-[(11R)-8-[3-(4,5-dihydro-1H-imidazol-2-ylamino)propyl]-3,6,9,12,15-pentaoxo-11-propan-2-yl-14-[[4-[3-[[6-[2-[(2-sulfophenyl)methylidene]hydrazinyl]pyridine-3-carbonyl]amino]propoxy]phenyl]methyl]-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid?
The canonical SMILES for 2-[(11R)-8-[3-(4,5-dihydro-1H-imidazol-2-ylamino)propyl]-3,6,9,12,15-pentaoxo-11-propan-2-yl-14-[[4-[3-[[6-[2-[(2-sulfophenyl)methylidene]hydrazinyl]pyridine-3-carbonyl]amino]propoxy]phenyl]methyl]-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid is CC(C)[C@H]1NC(=O)C(CCCNC2=NCCN2)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(Cc2ccc(OCCCNC(=O)c3ccc(NN=Cc4ccccc4S(=O)(=O)O)nc3)cc2)NC1=O.
What is the InChIKey of 2-[(11R)-8-[3-(4,5-dihydro-1H-imidazol-2-ylamino)propyl]-3,6,9,12,15-pentaoxo-11-propan-2-yl-14-[[4-[3-[[6-[2-[(2-sulfophenyl)methylidene]hydrazinyl]pyridine-3-carbonyl]amino]propoxy]phenyl]methyl]-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid?
The InChIKey is UQGHRBPUYPCKDD-WIXSAIQQSA-N. The full InChI is InChI=1S/C44H56N12O12S/c1-26(2)38-43(64)54-32(42(63)53-33(22-37(58)59)40(61)50-25-36(57)52-31(41(62)55-38)8-5-16-46-44-47-18-19-48-44)21-27-10-13-30(14-11-27)68-20-6-17-45-39(60)29-12-15-35(49-23-29)56-51-24-28-7-3-4-9-34(28)69(65,66)67/h3-4,7,9-15,23-24,26,31-33,38H,5-6,8,16-22,25H2,1-2H3,(H,45,60)(H,49,56)(H,50,61)(H,52,57)(H,53,63)(H,54,64)(H,55,62)(H,58,59)(H2,46,47,48)(H,65,66,67)/t31?,32?,33?,38-/m1/s1.
What are the key properties of 2-[(11R)-8-[3-(4,5-dihydro-1H-imidazol-2-ylamino)propyl]-3,6,9,12,15-pentaoxo-11-propan-2-yl-14-[[4-[3-[[6-[2-[(2-sulfophenyl)methylidene]hydrazinyl]pyridine-3-carbonyl]amino]propoxy]phenyl]methyl]-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid?
2-[(11R)-8-[3-(4,5-dihydro-1H-imidazol-2-ylamino)propyl]-3,6,9,12,15-pentaoxo-11-propan-2-yl-14-[[4-[3-[[6-[2-[(2-sulfophenyl)methylidene]hydrazinyl]pyridine-3-carbonyl]amino]propoxy]phenyl]methyl]-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid has a molecular weight of 977.07 g/mol, XLogP of -0.96, 19 rotatable bonds, 11 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(11R)-8-[3-(4,5-dihydro-1H-imidazol-2-ylamino)propyl]-3,6,9,12,15-pentaoxo-11-propan-2-yl-14-[[4-[3-[[6-[2-[(2-sulfophenyl)methylidene]hydrazinyl]pyridine-3-carbonyl]amino]propoxy]phenyl]methyl]-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid is sourced from PubChem (CID 58635064), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).